Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89,405 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab for bulky locally advanced non-small-cell lung cancer: protocol for a randomized phase II trial (InTRist study).
Wang Y, Deng L, Wang J, Zhang T, Wang W, Wang X, Liu W, Wu Y, Lv J, Feng Q, Zhou Z, Wang J, Wang L, Wang Z, Bi N. Wang Y, et al. Among authors: wang x, wang w, wang l, wang j, wang z. Front Immunol. 2024 Jan 15;14:1341584. doi: 10.3389/fimmu.2023.1341584. eCollection 2023. Front Immunol. 2024. PMID: 38288117 Free PMC article.
Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma.
Han W, Deng W, Wang Q, Ni W, Li C, Zhou Z, Liang J, Chen D, Feng Q, Bi N, Zhang T, Wang X, Deng L, Wang W, Liu W, Wang J, Xue Q, Mao Y, Liu X, Fang D, Li J, Wang D, Zhao J, Xiao Z. Han W, et al. Among authors: wang x, wang w, wang j, wang d, wang q. Front Oncol. 2022 Nov 10;12:998238. doi: 10.3389/fonc.2022.998238. eCollection 2022. Front Oncol. 2022. PMID: 36439431 Free PMC article.
Effectiveness of S-1-Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
Wang X, Han W, Zhang W, Wang X, Ge X, Lin Y, Zhou H, Hu M, Wang W, Liu K, Lu J, Qie S, Zhang J, Deng W, Wang L, Han C, Li M, Zhang K, Li L, Wang Q, Shi H, Yu Z, Zhao Y, Sun X, Shi Y, Pang Q, Zhou Z, Liang J, Chen D, Feng Q, Bi N, Zhang T, Deng L, Wang W, Liu W, Wang J, Zhai Y, Wang J, Chen W, Chen J, Xiao Z; Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG). Wang X, et al. Among authors: wang w, wang l, wang j, wang q. JAMA Netw Open. 2023 May 1;6(5):e2312625. doi: 10.1001/jamanetworkopen.2023.12625. JAMA Netw Open. 2023. PMID: 37195667 Free PMC article. Clinical Trial.
Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors in patients with stage III non-small cell lung cancer.
Yang Y, Wang J, Zhang T, Zhou Z, Wang Y, Jiang Y, Liu W, Xiao Z, Deng L, Feng Q, Wang X, Lv J, Wang W, Xue Q, Wang J, Li YX, Bi N. Yang Y, et al. Among authors: wang x, wang w, wang j, wang y. Front Immunol. 2023 Nov 24;14:1281888. doi: 10.3389/fimmu.2023.1281888. eCollection 2023. Front Immunol. 2023. PMID: 38077319 Free PMC article.
Immune-related adverse events of immune checkpoint inhibitors combined with angiogenesis inhibitors: A real-world pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database (2014-2022).
Ren X, Wang H, Deng L, Wang W, Wang Y. Ren X, et al. Among authors: wang h, wang w, wang y. Int Immunopharmacol. 2024 Jul 30;136:112301. doi: 10.1016/j.intimp.2024.112301. Epub 2024 Jun 4. Int Immunopharmacol. 2024. PMID: 38838553 Free article.
Effectiveness and safety of combined nimotuzumab and S-1 chemotherapy with concurrent radiotherapy for locally advanced esophageal cancer in malnourished and elderly patients: A prospective phase II study.
Feng G, Li J, Yu N, Zheng Z, Yang X, Deng L, Zhang T, Wang W, Liu W, Wang J, Feng Q, Lyu J, Xiao Z, Zhou Z, Bi N, Qin J, Wang X. Feng G, et al. Among authors: wang x, wang w, wang j. Chin J Cancer Res. 2024 Jun 30;36(3):270-281. doi: 10.21147/j.issn.1000-9604.2024.03.04. Chin J Cancer Res. 2024. PMID: 38988486 Free PMC article.
The time-series behavior of systemic inflammation-immune status in predicting survival of locally advanced non-small cell lung cancer treated with chemoradiotherapy.
Zhang T, Wang J, Wang D, Xu K, Wu L, Wang X, Wang W, Deng L, Liang J, Lv J, Hui Z, Zhou Z, Feng Q, Xiao Z, Chen D, Wang J, Wang L, Bi N. Zhang T, et al. Among authors: wang x, wang w, wang l, wang j, wang d. J Natl Cancer Cent. 2021 Nov 10;2(1):33-40. doi: 10.1016/j.jncc.2021.11.003. eCollection 2022 Mar. J Natl Cancer Cent. 2021. PMID: 39035216 Free PMC article.
Hippocampal avoidance whole-brain radiotherapy with simultaneous integrated boost in lung cancer brain metastases and utility of the Hopkins verbal learning test for testing cognitive impairment in Chinese patients: a prospective phase II study.
Li Z, Wang J, Deng L, Zhai Y, Zhang T, Bi N, Wang J, Wang X, Liu W, Xiao Z, Chen D, Lv J, Feng Q, Wang W, Zhou Z. Li Z, et al. Among authors: wang x, wang w, wang j. BMC Cancer. 2024 Jul 26;24(1):899. doi: 10.1186/s12885-024-12559-1. BMC Cancer. 2024. PMID: 39060968 Free PMC article. Clinical Trial.
Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort study.
Yu N, Chen X, Li J, Kang X, Wang Z, Zhang R, Qin J, Li Y, Zheng Q, Feng G, Deng L, Zhang T, Wang W, Liu W, Wang J, Feng Q, Lv J, Zhou Z, Xiao Z, Bi N, Li Y, Wang X. Yu N, et al. Among authors: wang x, wang w, wang z, wang j. Strahlenther Onkol. 2024 Dec;200(12):1038-1046. doi: 10.1007/s00066-024-02286-8. Epub 2024 Aug 12. Strahlenther Onkol. 2024. PMID: 39134689 Free PMC article. Clinical Trial.
89,405 results
You have reached the last available page of results. Please see the User Guide for more information.